🇺🇸 FDA
Patent

US 8519137

Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

granted A61PA61P1/02A61P1/04

Quick answer

US patent 8519137 (Heteroaryl amides useful as inhibitors of voltage-gated sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/18, A61P11/02